Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor
- 23 August 2003
- journal article
- laboratory investigation
- Published by Springer Nature in Albrecht von Graefes Archiv für Ophthalmologie
- Vol. 241 (9) , 765-772
- https://doi.org/10.1007/s00417-003-0688-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Age-Related Macular DegenerationNew England Journal of Medicine, 2000
- Utilization of Distinct Signaling Pathways by Receptors for Vascular Endothelial Cell Growth Factor and Other Mitogens in the Induction of Endothelial Cell ProliferationJournal of Biological Chemistry, 2000
- Ocular NeovascularizationSurvey of Ophthalmology, 1998
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Increased expression of angiogenic growth factors in age-related maculopathyBritish Journal of Ophthalmology, 1997
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cellsBiochemical and Biophysical Research Communications, 1987
- Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growthNature, 1987